Disease modifying therapies modulate retinal layer atrophy in multiple sclerosis: a longitudinal study

被引：0
|
作者：
Al-Louzi, O. [1 ]
Button, J. [1 ]
Lang, A. [2 ]
Bhargava, P. [1 ]
Newsome, S. [1 ]
Carass, A. [2 ]
Balcer, L. [3 ]
Frohman, E. [4 ]
Prince, J. [2 ]
Calabresi, P. [1 ]
Saidha, S. [1 ]
机构：
[1] Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA
[3] NYU, Dept Neurol, New York, NY 10016 USA
[4] Univ Texas Southwestern, Dept Neurol, Dallas, TX USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1009
引用
收藏
页码：514 / 515
页数：2
相关论文
共 50 条
  • [1] Disease Modifying Therapies Modulate Retinal Atrophy in Multiple Sclerosis: A Retrospective Study
    Button, Julia
    Al-Louzi, Omar
    Lang, Andrew
    Bhargava, Pavan
    Newsome, Scott
    Balcer, Laura
    Frohman, Elliot
    Prince, Jerry
    Calabresi, Peter
    Saidha, Shiv
    NEUROLOGY, 2016, 86
  • [2] Disease-modifying therapies modulate retinal atrophy in multiple sclerosis A retrospective study
    Button, Julia
    Al-Louzi, Omar
    Lang, Andrew
    Bhargava, Pavan
    Newsome, Scott D.
    Frohman, Teresa
    Balcer, Laura J.
    Frohman, Elliot M.
    Prince, Jerry
    Calabresi, Peter A.
    Saidha, Shiv
    NEUROLOGY, 2017, 88 (06) : 525 - 532
  • [3] A prospective study of disease modifying therapy and retinal atrophy in multiple sclerosis
    Kabanovski, A.
    Zaslavsky, K.
    Rotstein, D.
    Margolin, E.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 917 - 917
  • [4] Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Patients with Multiple Sclerosis
    Sternberg, Zohara
    Leung, Christopher
    Sternberg, Daniel
    Yu, Jinhee
    Hojnacki, David
    CARDIOVASCULAR THERAPEUTICS, 2014, 32 (02) : 33 - 39
  • [5] A prospective study of disease modifying therapy and retinal atrophy in relapsing-remitting multiple sclerosis
    Kabanovski, Anna
    Zaslavsky, Kirill
    Rotstein, Dalia
    Margolin, Edward
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 446
  • [6] Disease modifying therapies in multiple sclerosis
    Sharrack, B.
    Jenkins, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 532 - 534
  • [7] Disease modifying therapies in multiple sclerosis
    Khatri, BO
    McQuillen, MP
    NEUROLOGY, 2002, 59 (03) : 471 - 472
  • [8] Retinal nerve fiber layer atrophy in patients with multiple sclerosis: Longitudinal 5 years study
    Martin, E. Garcia
    Satue, M.
    Rodrigo, M. J.
    Obis, J.
    Alastuey, M. Cipres
    Vilades, E.
    Otin, S.
    Polo, V.
    Larrosa, J. M.
    Pablo, L.
    Gracia, H.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [9] Longitudinal study of retinal layer thinning and brain atrophy in clinically isolated syndrome and multiple sclerosis
    Huang-Link, Yumin
    Borgstrom, Max
    Tisell, Anders
    Wilhelm, Elisabeth
    Lundberg, Peter
    Link, Hans
    NEUROLOGY, 2019, 92 (15)
  • [10] Impact of disease-modifying therapies on brain and spinal cord atrophy in multiple sclerosis
    Rudick, RA
    JOURNAL OF NEUROIMAGING, 2004, 14 (03) : 54S - 64S
12345